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Abstract
Several epidemiological and clinical studies have indicated that the prevalence of psychiatric
disorders is higher in diabetic patients than in the general population. In the present studies, we ex-
amined the behavioral changes in streptozotocin-induced diabetic rats, and investigated the effects
of physical and psychological stress on the hippocampal BDNF levels and on the serotonin 2A (5-
HT2A) receptor-mediated wet-dog shake responses. The streptozotocin (60 mg/kg, i.p.)-induced
diabetes had no significant effects on the immobility time in the forced swim test or on locomotor
activity in the open-field test. Moreover, there was no significant difference in the wet-dog shake
responses induced by DOI, a 5-HT2A receptor agonist, between nondiabetic and diabetic rats.
Five-day exposure to physical (electric footshock) and psychological (non-footshock) stress had
no signifi cant effect on the hippocampal BDNF level in diabetic or nondiabetic rats. The 2 types
of stress had no significant effect on the DOI-induced wet-dog shake responses in nondiabetic
rats. In diabetic rats, the repeated exposure to physical stress markedly increased the DOI-induced
wet-dog shake responses, but the repeated exposure to psychological stress had no effect. These
results suggest that exposure to physical stress augmented the susceptibility to the wet-dog shake
responses to 5-HT2A receptor stimulation in streptozotocin-induced diabetic rats.
KEYWORDS: streptozotocin, physical stress, psychological stress, 5-HT2A receptor, wet-dog
shake
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tress has been suggested to be an important 
etiological factor in many psychiatric diseases.  
In addition,  epidemiological and clinical studies have 
shown that diabetes is related to psychiatric disorders,  
including depression.  Investigators have found that 
major depression was present in 14.7ｵ,  and elevated 
depression symptoms in 26ｵ of diabetic patients [1],  
and that the incidence of psychiatric disorders is 
equally common in those with either type 1 or type 2 
diabetes [2].  Although the factors associated with the 
development of depression remain unclear,  it is com-
monly assumed that the development and exacerbation 
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of disease probably results from an interaction among 
psychological,  physical and genetic factors [2].
　 Postsynaptic serotonergic responses to stress are 
mediated by a number of diﬀ erent serotonin (5-HT) 
receptor subtypes.  Among them,  the subtypes,  the 
5-HT2A receptor plays special roles in the serotoner-
gic responses to stress,  and has been suggested to be 
involved in aﬀ ective disorders,  anxiety disorders and 
depression [3,  4].  Several studies have found ele-
vated numbers of 5-HT2A receptors in the post-mortem 
brains of suicide victims and depressed subjects [5,  
6].  Recently,  neurotrophins and 5-HT have both been 
implicated in the pathophysiology of depression and in 
the mechanisms of antidepressant treatments.  Protein 
immunoreactivity of brain-derived neurotrophic factor 
(BDNF),  a member of the neurotrophin superfamily,  
is reduced in both the prefrontal cortex and hippocam-
pus of suicide subjects [7],  and is elevated in the 
post-mortem tissue from antidepressant-treated 
patients [8].  Moreover,  it has been reported that 
BDNF promotes 5-HT neuron development [9],  and 
augments 5-HT synthesis and turnover [10,  11].  
Interestingly,  it has also been reported that immobili-
zation stress decreases the expression of BDNF 
within the rat hippocampus,  and that pretreatment 
with 5-HT2A receptor antagonists blocks the eﬀ ects of 
stress on BDNF expression [12].
　 The streptozotocin-induced hyperglycemic state has 
been used as an animal model for diabetes mellitus,  
and some experiments have been conducted in animal 
models to study the relationships between diabetes and 
anxiogenic or depressive behavior [13].  However,  the 
eﬀ ects of physical and psychological stress on 5-HT2A 
receptors and BDNF are not clear.  In order to study 
the responses or physiological changes caused by 
physical and psychological stress,  various laboratory 
techniques,  such as forced swim stress,  footshock 
stress and social stress,  have been used [13ﾝ15].  
One of these methods,  an apparatus called a communi-
cation box,  subjects animals to both psychological 
stress and physical stress at the same time [16].  In 
the communication box paradigm,  one group of animals 
receives electric footshocks and the resulting distress 
responses are allowed to reach the unshocked animals 
in neighboring boxes.  These stress exposures have 
been demonstrated to cause both acute and chronic 
behavioral and physiological changes in animals [15,  
17].  On the other hand,  DOI,  a 5-HT2A receptor 
agonist,  produces wet-dog shakes,  and this behavior 
is useful for studying the function of 5-HT2A recep-
tors [18].  Thus,  in the present study,  we used the 
communication box paradigm to investigate the eﬀ ect 
of physical and psychological stress on DOI-induced 
wet-dog shake responses and hippocampal BDNF lev-
els in streptozotocin-induced diabetic rats.
Materials and Methods
　 Animals. Male Wistar strain rats (at 6ﾝ7 
weeks of age) were obtained from Charles River 
(Yokohama,  Japan).  All animals were housed at 2 
rats/cage (42 cm long×26 cm wide×15 cm high).  
The animal room was maintained at 22±1°C under a 
12 h/12 h light/dark cycle with lights on from 7:00 
AM.  Food and water were available ad libitum.  
Animals were rendered diabetic by an injection of 
streptozotocin (60 mg/kg,  i.p.).  The control rats were 
injected with the vehicle alone.  Blood glucose levels 
were determined using a glucose analyzer (Arkray 
Glucocard Diameter-alpha GT-1661; ARKRAY Inc.,  
Kyoto,  Japan).  Animal experiments were performed 
in compliance with the Guidelines for Animal 
Experimentation and with the approval of the 
Committee of Animal Experimentation,  Ehime 
University School of Medicine.
　 Drugs. Streptozotocin (Sigma-Aldrich Co.,  St.  
Louis,  MO,  USA) was dissolved in 0.05 M citrate 
buﬀ er at pH 4.5 immediately before administration.  
(±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane 
(DOI; Sigma-Aldrich Co.) was dissolved in saline.  All 
drugs were injected at a volume of 0.1 ml per 100 g 
body weight.
　 Experimental procedures. Experiment 1:
Behavioral changes in diabetic rats (Fig.  1).  Two 
groups of animals were established to investigate the 
behavioral changes,  and 8ﾝ11 animals were used for 
each group.  The forced swim test,  elevated plus-maze 
test and DOI-induced wet-dog shake responses were 
examined for 14 days after the administration of 
streptozotocin or vehicle.  Locomotor activity was 
measured for 13 days after the administration using an 
open-ﬁ eld apparatus.
　 Experiment 2: Eﬀ ect of physical and psychologi-
cal stress on BDNF levels and 5-HT2 agonist-induced 
behavior.  Six groups of animals (n＝6 for each group) 
were established to investigate the eﬀ ects of physical 
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and psychological stress on the BDNF levels in the 
hippocampus and on the DOI-induced wet-dog shake 
responses in the streptozotocin-induced diabetic rats.  
Three groups were administered streptozotocin,  and 
the other 3 groups were administered vehicle.  Seven 
days after the injections,  the rats were exposed to 2 
types of stress,  physical (electric footshock) stress and 
psychological (non-footshock) stress for 5 days; i.e., 2 
of the groups that had received streptozotocin or 
vehicle were exposed to physical stress,  2 were 
exposed to psychological stress,  and 2 were not 
exposed to stress (control).  Six groups were thus 
formed: a nondiabetic-control group,  nondiabetic-
physical stress-exposed group,  nondiabetic-psycholog-
ical stress-exposed group,  diabetic-control group,  
diabetic-physical stress-exposed group,  and diabetic-
psychological stress-exposed group.  Each group was 
administered DOI 24 h after the last exposure to 
physical or psychological stress.  All behavioral obser-
vations were performed between 10:00 AM and 4:00 
PM each day.
　 Physical and psychological stress exposures.
Physical and psychological stress was administered 
using a communication box (Fig.  2) according to the 
method of Funada and Hara [19].  This box (53×53
×44 cm) was equipped with a ﬂ oor grid composed of 
0.5 cm-diameter stainless steel rods placed 1.3 cm 
apart.  The box consisted of 9 small compartments (17
×17 cm) divided by transparent plastic walls.  Plastic 
plates were placed on the grid ﬂ oors of 5 compart-
ments to prevent the rats from receiving electric 
shocks.  An electric footshock generator (MSG-
001; Toyo Sangyo,  Toyama,  Japan) was used to pro-
duce a scrambled electric footshock (2 mA) through 
the ﬂ oor grid lasting for 10 sec at intervals of 90 sec 
for 30 min.
　 Forced swim test. The forced swim test was 
performed 14 days after the administration of strep-
tozotocin.  It was carried out in a cylindrical container 
(15.5 cm diameter,  37 cm height) ﬁ lled with water to 
a depth of 20 cm,  as described by Porsolt et al.  [20].  
The water was maintained at 25±1 °C.  On the day 
before the forced swim test,  each animal was placed 
in the cylinder for a 13-min preswim.  Following swim-
ming,  the animals were dried with a towel and kept 
warm before returning to the home cage.  On the 
forced swim test day,  immobility times were recorded 
during the 6-min swim test using a digital video cam-
era.  All data was calculated using Ethovision 3.0 
(Noldus Information Technology,  Wageningen,  the 
Netherlands).
　 Open-ﬁ eld test. In order to investigate general 
changes in activity,  rats were assessed for changes in 
locomotor activity 13 days after the administration of 
streptozotocin.  For the open-ﬁ eld test,  rats were 
individually placed in an acrylic apparatus (69 cm in 
diameter×28 cm high wall) with the gray ﬂ oor 
divided into 19 squares.  Locomotor activity (grid lines 
crossed with the 4 paws) was measured during a 
period of 6 min.  Illumination was provided by a bulb 
(100 W) placed above the center of the ﬁ eld,  while the 
rest of the room was in darkness.
　 Elevated plus-maze test. Anxiety-related 
behavior was evaluated using the plus-maze test.  The 
plus-maze,  consisting of 2 opposite open arms (50×
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Fig. 1　 Schematic presentation of the protocol.
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Fig. 2　 Schematic presentation of a communication box.
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10 cm) and 2 enclosed arms (50×10×40 cm) was 
elevated 50 cm above the ﬂ oor.  The arms extended 
from a central platform (10×10 cm).  Rats were 
placed individually on the central platform and were 
allowed to enter freely into both the open and enclosed 
arms.  The behavior of each rat over an 8-min period 
was monitored by using a video camera.  Arm entry 
was deﬁ ned as the entry of all 4 paws into 1 arm.  The 
time spent in the open arms and enclosed arms,  and 
the number of open and enclosed arm entries,  were 
recorded.  The time spent in open arms (time in open 
arms) and the number of entries into open arms (open 
arm entries) were calculated as the percentage of the 
time spent in all 4 arms,  and of the total arm entries,  
respectively.
　 DOI-induced wet-dog shakes. Rats were 
placed individually into clean,  transparent plastic 
cages (42 cm long×26 cm wide×15 cm high).  
Immediately after the subcutaneous administration of 
DOI (1 mg/kg),  the number of wet-dog shakes was 
recorded over a 30-min period.
　 Measurement of BDNF protein. At 24 h 
after the last exposure to physical and psychological 
stress,  the animals were sacriﬁ ced by decapitation.  
The brains were quickly removed and dissected on ice,  
separating the hippocampus.  Samples were frozen at
－80 °C before homogenization.  Sections were 
homogenized in a lysis buﬀ er (137 mM NaCl,  20 mM 
TRIS,  1ｵ NP40,  10ｵ glycerol,  1 mM phenylmeth-
ylsulfonyl ﬂ uoride (PMSF),  10 ｻg/ml aprotinin,  1 ｻ
g/ml leupeptin,  0.5 mM sodium vanadate).  The 
homogenates were centrifuged at 10,000×g for 
20 min,  and the supernatants were collected and pro-
cessed for quantiﬁ cation of BDNF with a BDNF 
Emax Immuno Assay System kit (Promega,  Madison,  
WI,  USA).  An enzyme-linked immunosorbent assay 
(ELISA) was performed using the BDNF Emax 
Immuno Assay System Kit (Promega) according to the 
manufacturer’s instructions [21].  Nunc Maxisorp 
96-well immunoplates were coated with 100 ｻl/well of 
Anti-BDNF Monoclonal Antibody and incubated over-
night at 4 °C.  The plates were then incubated in a 
block and sample buﬀ er at room temperature for 1 h.  
Next,  the samples were added to the coated wells 
(100 ｻl) and shaken for 2 h at room temperature.  The 
antigen was incubated with an Anti-Human BDNF 
polyclonal antibody for 2 h at room temperature with 
shaking,  and then with an anti-IgY antibody conjugated 
to horseradish peroxidase (HRP) for 1 h at room tem-
perature.  Finally,  the plates were incubated with 
tetramethylbenzidine solution for 15 min,  and 1 M 
hydrochloric acid was added to the wells.  The colori-
metric reaction product was measured at 450 nm.  
Standard curves were plotted for each plate.  BDNF 
concentrations were determined from the regression 
line for the BDNF standard provided by Promega,  
which ranged from 7.8 to 500 pg/ml.  Values of sec-
tions were above 16 pg/ml for each plate.
　 Statistical analysis. Values are expressed as 
the means and S.E.M.  of each group.  Data were ana-
lyzed using Student’s t-test or one-way analysis of 
variance (ANOVA) followed by Tukey’s test.  P values 
less than 0.05 were considered signiﬁ cant.
Results
　 Experiment 1: Behavioral changes in dia-
betic rats. Fig.  3 shows the results of the forced 
swim test and open-ﬁ eld test.  Student’s t-test revealed 
no signiﬁ cant diﬀ erences in the duration of the immo-
bility time in the forced swim test between diabetic 
and nondiabetic rats.  The locomotor activity in the 
open-ﬁ eld apparatus was also not diﬀ erent between the 
groups (Student’s t-test).
　 Fig.  4 shows the eﬀ ect of streptozotocin-induced 
diabetes on the elevated plus-maze test.  There were 
no signiﬁ cant diﬀ erences in the percent duration of 
open arm entries or the number of open arm entries 
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between the diabetic and nondiabetic rats.
　 Experiment 2: Eﬀ ect of physical and psy-
chological stress. Table 1 shows the eﬀ ect of 
physical and psychological stress on the body weight 
and blood glucose levels in diabetic or nondiabetic 
rats.  The body weight of the nondiabetic-control 
group was not signiﬁ cantly diﬀ erent from that of the 
diabetic-control group 14 days after streptozotocin 
administration.  Exposure to physical and psychologi-
cal stress had no eﬀ ect on the body weight in the non-
diabetic rats,  but the body weight of the diabetic-
physical stress-exposed group was signiﬁ cantly lower 
compared with that of the diabetic-control group.  
However,  psychological stress did not have any eﬀ ect 
on the body weight of the diabetic rats.  
Streptozotocin treatment signiﬁ cantly increased blood 
glucose levels.  Both physical and psychological stress 
had no eﬀ ect on the blood glucose levels in the nondia-
betic and diabetic rats.
　 Fig.  5 shows the eﬀ ect of physical and psycholog-
ical stress on DOI-induced wet-dog shakes in diabetic 
or nondiabetic rats.  One-way ANOVA revealed a sig-
niﬁ cant eﬀ ect on DOI-induced wet-dog shake 
responses [F(5, 30)＝8.732,  p＜0.0001].  The post hoc 
comparisons using Tukey’s test showed signiﬁ cantly 
higher wet-dog shake responses in the diabetic-physi-
cal stress-exposed group (p＜0.001,  respectively) 
compared with those in the nondiabetic-physical 
stress-exposed group,  diabetic-control group or dia-
betic-psychological stress-exposed group.  However,  
exposure to physical and psychological stress had no 
signiﬁ cant eﬀ ect on the hippocampal BDNF protein 
level in diabetic or nondiabetic rats (Fig.  6).
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Table 1　 The eﬀ ect of physical and psychological stress on the blood glucose levels and body weight in streptozotocin- or vehicle-
treated rats
Nondiabetic Diabetic
Control Physicalstress
Psychological
stress Control
Physical
stress
Psychological 
tress
Body weight (g) 285.7±3.52 280.0±3.43 297.7±3.32 282.3±7.05 241.0±14.75# 271.8±22.44
Blood glucose
level (mg/dL) 92.3±4.34 98.7±6.16 111.0±8.56 374.3±76.30
＊＊ 357.3±60.04 326.8±92.80
Each value represents the mean±S.E.M.  (n＝6).  ＊＊p＜0.01 vs nondiabetic control,  ＃p＜0.05 vs diabetic control (one-way ANOVA 
followed by Tukey’s test).
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Discussion
　 Diabetes has been reported to induce behavioral 
changes in animals.  Ramanathan et al.  [22] reported 
that streptozotocin-induced diabetic rats showed sig-
niﬁ cantly more anxiogenic activity than nondiabetic 
rats in the elevated plus-maze,  zero-maze and social 
interaction tests,  when these experiments were per-
formed 3 days after streptozotocin administration.  
Hilakivi-Clarke et al.  [13] reported no signiﬁ cant 
eﬀ ect on the plus-maze test of anxiety,  but there was 
a signiﬁ cantly lengthened immobility time in the forced 
swim test,  a putative animal model of depression,  in 
streptozotocin-treated mice.  Furthermore,  Kamei et 
al.  [23] reported that immobility time was signiﬁ -
cantly longer in diabetic than in nondiabetic mice in the 
tail suspension test.  In the present study,  strepto-
zotocin-induced diabetes showed a tendency to increase 
the duration of open arm entries in the elevated plus-
maze test and the immobility time in the forced swim 
test.  However,  there were no statistically signiﬁ cant 
diﬀ erences compared to nondiabetic control rats,  indi-
cating that the diabetic rats do not have markedly 
higher anxiogenic activity or a markedly higher degree 
of depression than the nondiabetic rats.  In addition,  
streptozotocin-induced diabetes showed a tendency to 
reduce locomotor activity in the open-ﬁ eld test.  
Several studies have shown that basal locomotor 
activity of streptozotocin-treated rats is lower than 
that of control rats [13,  23],  but it has also been 
shown that amphetamine-induced hyperlocomotor 
activity increases in streptozotocin-treated rats [24].  
Therefore,  these diﬀ erences in the behavioral changes 
in diabetic animals may be related to diﬀ erences in the 
experimental conditions,  strain or period after strep-
tozotocin administration.
　 Both systemic administration and microinjection of 
DOI into the medial prefrontal cortex elicit dose-
dependent wet-dog shake or head- twitch responses 
[25,  26].  These responses can be blocked by selec-
tive 5-HT2A receptor antagonists,  indicating that they 
are mediated by central 5-HT2A receptors [25,  27].  
These ﬁ ndings indicate that these responses are medi-
ated by central 5-HT2A receptors.  Miyata et al.  
reported that streptozotocin-induced diabetes produces 
long-lasting increases in 5-HT turnover rates in the 
mouse midbrain and frontal cortex [28].  In addition,  
they found that streptozotocin-induced diabetes inhib-
its the DOI-induced head-twitch response in mice,  but 
that the number and aﬃ  nity of 5-HT2A receptors in the 
frontal cortex are not aﬀ ected by diabetes [29].  
Thus,  the detailed mechanism of the decreased head-
twitch response in diabetic mice is still unknown.  In 
the present study,  streptozotocin-induced diabetes had 
no eﬀ ect on the wet-dog shake responses induced by 
DOI in rats.
　 Repeated exposure to social or physical stressors 
increases the density of 5-HT2A receptors in the cor-
tex [30,  31],  and exposure to 63 days of psychologi-
cal stress (strobe light and white noise) or 14 days of 
forced swim stress was reported to increase the DOI-
stimulated wet-dog shake responses [30,  32].  In this 
study,  5 days of exposure to physical and psychologi-
cal stress using a communication box had no signiﬁ cant 
eﬀ ect on the DOI-induced wet-dog shake responses in 
nondiabetic rats.  However,  in streptozotocin-induced 
diabetic rats,  the wet-dog shake responses were aug-
mented by exposure to physical stress,  but psycho-
logical stress had no eﬀ ect.  These results suggest the 
increased vulnerability of 5-HT receptors to physical 
stress in diabetics.  Thorre et al. [33] reported that 
streptozotocin-induced diabetes reduces 5-HT synthe-
sis and metabolism in rat brains,  and a hippocampal 
microdialysis study has shown that the extracellular 
5-HT levels increase throughout restraint stress in 
vehicle-,  but not in streptozotocin-pretreated rats.  
These ﬁ ndings suggest that the number of 5-HT2A 
receptors in the brains of the diabetic-physical stress-
exposed group may have been increased via a feed-
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back-control mechanism.  Taken together,  these ﬁ nd-
ings and the results of the current study suggest that 
exposure to physical stress increased the susceptibil-
ity to the wet-dog shake responses to 5-HT2A receptor 
stimulation in streptozotocin-induced diabetic rats.  
However,  further studies are needed to determine 
whether or not selective 5-HT2A receptor antagonists 
block the increased wet-dog shake responses in dia-
betic-physical stress-exposed rats.
　 Generally,  there are several possible explanations 
for the diﬀ erences between the eﬀ ects of physical 
stress and psychological stress on the wet-dog shake 
responses in the streptozotocin-induced diabetic rats.  
First,  these diﬀ erences may be due to diﬀ erential 
eﬀ ects on the neurotransmitter systems.  Psycho-
logical stress has been reported to cause a mild 
enhancement of noradrenaline turnover in rat brain,  
whereas physical stress causes a remarkable increase 
in the noradrenaline turnover [34].  Moreover,  it has 
reported that exposure to psychological stress,  but not 
physical stress,  increases diazepam-binding inhibitor 
mRNA expression in mouse brains [35].  Another 
possible explanation is the endocrinological diﬀ erence.  
Previous studies have reported that physical stress,  
but not psychological stress,  increases the plasma 
corticosterone level in rats during psychological stress 
induced by the communication box [36].  In addition,  
the chronic administration of adrenocorticotropic hor-
mone (ACTH) increases plasma corticosterone levels 
and enhances the wet-dog shake response induced by 
DOI in rats [37].  Therefore,  the endocrinological 
diﬀ erences between physical and psychological stress 
may be responsible for the diﬀ erent eﬀ ects of these 
stressors regarding the eﬀ ects of physical and psycho-
logical stress on the wet-dog shake responses.
　 Seki et al.  [38] and Nitta et al.  [39] reported 
reduced protein and mRNA levels of BDNF in the 
cortex and hippocampus 4 weeks after streptozotocin 
administration.  However,  in the present study,  there 
was no signiﬁ cant eﬀ ect on the hippocampal BDNF 
protein level 2 weeks after streptozotocin administra-
tion.  This result indicates that the increased DOI-
induced wet-dog response in the diabetic-physical 
stress-exposed group was unrelated to BDNF expres-
sion.  However,  previous studies have shown that 
immobilization stress decreases the expression of 
BDNF within the rat hippocampus,  and pretreatment 
with 5-HT2A receptor antagonists blocks the eﬀ ects of 
stress on BDNF expression [12].  Moreover,  the 
downregulation of BDNF mRNA and protein in the rat 
hippocampus by corticosterone has been reported 
[40].  Thus,  further studies will be necessary to 
clarify the involvement of BDNF in the vulnerability 
to physical and psychological stress in diabetics.
　 In conclusion,  the major ﬁ nding of the present study 
was that exposure to physical stress augmented the 
susceptibility to wet-dog shake responses due to 5-HT2A 
receptor stimulation in streptozotocin-induced diabetic 
rats.  This ﬁ nding suggests that the increased sensitiv-
ity of the 5-HT2A receptor system may be related to 
some aspect of aﬀ ective disorder in diabetics.
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